Cooper Cos. | Income Statement

Fiscal year is November-October. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,588
1,718
1,797
1,967
2,139
2,533
Cost of Goods Sold (COGS) incl. D&A
591
647
716
791
819
1,021
Gross Income
997
1,071
1,081
1,176
1,320
1,512
SG&A Expense
670
726
721
764
838
1,015
EBIT
327
345
360
-
482
497
Unusual Expense
14
39
123
89
55
93
Non Operating Income/Expense
20
2
3
1
2
12
Interest Expense
9
8
18
26
31
83
Pretax Income
312
297
215
296
394
332
Income Tax
15
25
10
21
21
192
Consolidated Net Income
297
272
205
275
373
140
Net Income
296
270
204
274
373
140
Net Income After Extraordinaries
296
270
204
274
373
140
Net Income Available to Common
296
270
204
274
373
140
EPS (Basic)
5.96
5.51
4.14
5.59
7.52
2.81
Basic Shares Outstanding
49
48
49
49
49
49
EPS (Diluted)
5.96
5.51
4.14
5.59
7.52
2.81
Diluted Shares Outstanding
50
49
49
49
50
50
EBITDA
452
484
551
610
670
772
Minority Interest Expense
1
2
2
1
-
-

About Cooper Cos.

View Profile
Address
6140 Stoneridge Mall Road
Pleasanton California 94588
United States
Employees -
Website http://www.coopercos.com
Updated 07/08/2019
The Cooper Cos, Inc. operates as a medical device company. It operates through the following business units: Cooper Vision and Cooper Surgical. The Cooper Vision business unit brings a refreshing perspective on vision care with a commitment to crafting quality lenses for contact lens wearers.